Presented by Fortra
VP of Sales
Location: Remote

We are driven by a vision that every animal has access to the highest quality diagnostics. To achieve this, Moichor has harnessed cutting-edge technology to bring advances in precision and low costs.

  • Founded: 2019
  • Headquarters: San Francisco, CA
  • Number of Employees: ~27
  • Funding: $10M

Moichor is a passionate team of biologists, engineers, and clinical pathologists dedicated to disrupting animal medical diagnostics. Our team is building AI solutions in a diagnostics lab setting to provide faster, more precise, and insightful information for veterinarians in assessing their patients. We are a well-funded startup backed by Y-Combinator and other reputable institutions.




Moichor harnesses computer vision and AI to achieve results only made possible by high throughput image capture technology.

Born from a simple idea about how blood tests could be improved, Moichor has grown to offer a full suite of veterinary diagnostic solutions. Its groundbreaking automated blood test for avian and exotic species was the starting point for the company.


Moichor is driving advancements in the automation of microscopy and its applications of computer vision and artificial intelligence that will enable reference ranges for species that were not previously possible.

Why We're Hot


  • On pace to 3-4x revenue this year
  • Deal size for consolidators range in annual value from $500,000 to $20M+
  • Average sales cycle of independent is 3 months
  • 82% close rate of clinics that trial
  • In 2022, we expanded to 100+ clinics, 3x annual revenue, and processed 60,000+ tests.


Multi-billion dollar opportunity to replace big market with soft, complacent, old incumbent competition that customers are eager to replace.

Animal diagnostics, a $14B industry controlled by legacy companies with a combined market cap of $130B has experienced little innovation since 2008. Despite pets playing a critical role for 70% of US households, the use of AI and data is nearly non-existent. As a result, veterinarians are stuck with subpar and expensive diagnostics.


  • IDEXX $40B Market Cap
  • Antech Diagnostics $2.8B Market Cap
  • Annual price increases 3-5%
  • Utilize legacy technology and completely disregard data. As a result, Moichor system catches 20% more abnormalities leading to more revenue for vets and better outcomes


The Vice President of Sales is responsible for developing strategic sales plans based on company goals to promote sales growth, develop and lead a high-performing sales team that achieves team goals and targets, and customer satisfaction for the organization.

  • Responsible for all new revenue generation, including new logo sales, cross-sales to existing clients, competitive client renewal
  • Recruit A-level reps and create rep onboarding/management procedures
  • Review the sales team territories to ensure equitable/efficient distribution
  • Focus on pipeline growth and execution
  • Proven ability to creatively develop and manage a geographically distributed sales team and successfully drive strategy, planning, reporting, and execution
  • Well-versed in technologies and can speak to the resulting impact on business processes
  • An inspirational leader with a proven ability to build high-performing teams and foster a collaborative culture
  • Entrepreneurial with a strong ability to work in a less-structured environment across several locations
  • Pragmatic and hard-working, hands-on approach
  • Hi EQ. Low ego
Executive Team

Shevy Karbasi – Co-Founder

Matthew Chen – Co-Founder

Thanh Le – CTO, Co-Founder

David Stone-Resnek – Head of Marketing

Get In Touch